83 related articles for article (PubMed ID: 11394702)
21. Behavior of soluble HLA-A, -B, -C and HLA-G molecules in patients with chronic hepatitis C virus infection undergoing pegylated interferon-α and ribavirin treatment: potential role as markers of response to antiviral therapy.
Murdaca G; Contini P; Cagnati P; Marenco S; Pieri G; Lantieri F; Picciotto A; Puppo F
Clin Exp Med; 2017 Feb; 17(1):93-100. PubMed ID: 26567007
[TBL] [Abstract][Full Text] [Related]
22. HLA-DRB1*1301 and *1302 protect against chronic hepatitis B.
Höhler T; Gerken G; Notghi A; Lubjuhn R; Taheri H; Protzer U; Löhr HF; Schneider PM; Meyer zum Büschenfelde KH; Rittner C
J Hepatol; 1997 Mar; 26(3):503-7. PubMed ID: 9075656
[TBL] [Abstract][Full Text] [Related]
23. Blood serum glutathione alpha s-transferase (alpha GST) activity during antiviral therapy in patients with chronic hepatitis C.
Mazur W; Gonciarz M; Kajdy M; Mazurek U; Jurzak M; Wilczok T; Gonciarz Z
Med Sci Monit; 2003 Aug; 9 Suppl 3():44-8. PubMed ID: 15156612
[TBL] [Abstract][Full Text] [Related]
24. Soluble beta2-mu-associated and beta2-mu-free HLA class I heavy chain serum levels in interferon-alpha nonresponder chronic hepatitis C patients. Markers of immune activation, and response to antiviral retreatment.
Puppo F; Torre F; Contini P; Ghio M; Brenci S; Brizzolara R; Sinelli N; Campo N; Indiveri F; Picciotto A
J Clin Immunol; 2000 Nov; 20(6):486-90. PubMed ID: 11202239
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of interferon for chronic hepatitis C virus-related hepatitis in kidney transplant candidates on hemodialysis: results after transplantation.
Casanovas-Taltavull T; Baliellas C; Benasco C; Serrano TT; Casanova A; Pérez JL; Guerrero L; González MT; Andres E; Gil-Vernet S; Casais LA
Am J Gastroenterol; 2001 Apr; 96(4):1170-7. PubMed ID: 11316166
[TBL] [Abstract][Full Text] [Related]
26. HLA class I B44 is associated with sustained response to interferon + ribavirin therapy in patients with chronic hepatitis C.
Romero-Gómez M; González-Escribano MF; Torres B; Barroso N; Montes-Cano MA; Sánchez-Muñoz D; Núñez-Roldan A; Aguilar-Reina J
Am J Gastroenterol; 2003 Jul; 98(7):1621-6. PubMed ID: 12873589
[TBL] [Abstract][Full Text] [Related]
27. Neutralizing antibodies to interferon-α and circulating interferon in patients with chronic hepatitis C non-responding to pegylated interferon plus ribavirin re-treated by pegylated interferon-α-2a and ribavirin (ANRS HC16 GAMMATRI substudy).
Halfon P; Pérusat S; Bourlière M; Bronowicki JP; Trimoulet P; Benhamou Y; Leroy V; Marcellin P; Foucher J; Penaranda G; Chêne G; Couzigou P;
J Med Virol; 2010 Dec; 82(12):2027-31. PubMed ID: 20981789
[TBL] [Abstract][Full Text] [Related]
28. Multispecific T cell response and negative HCV RNA tests during acute HCV infection are early prognostic factors of spontaneous clearance.
Spada E; Mele A; Berton A; Ruggeri L; Ferrigno L; Garbuglia AR; Perrone MP; Girelli G; Del Porto P; Piccolella E; Mondelli MU; Amoroso P; Cortese R; Nicosia A; Vitelli A; Folgori A
Gut; 2004 Nov; 53(11):1673-81. PubMed ID: 15479691
[TBL] [Abstract][Full Text] [Related]
29. Treatment of hepatitis C virus infection in patients of northern India.
Hazari S; Panda SK; Gupta SD; Batra Y; Singh R; Acharya SK
J Gastroenterol Hepatol; 2004 Sep; 19(9):1058-65. PubMed ID: 15304125
[TBL] [Abstract][Full Text] [Related]
30. [A 5-year follow-up study of antiviral effect of interferon in patients with chronic hepatitis C].
Jiang Y; Yao J; Peng W
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Dec; 12(4):373-6. PubMed ID: 12526359
[TBL] [Abstract][Full Text] [Related]
31. Human leukocyte antigen class I and II alleles and response to interferon-alpha treatment, in Taiwanese patients with chronic hepatitis C virus infection.
Yu ML; Dai CY; Chen SC; Chiu CC; Lee LP; Lin ZY; Hsieh MY; Wang LY; Chuang WL; Chang WY
J Infect Dis; 2003 Jul; 188(1):62-5. PubMed ID: 12825172
[TBL] [Abstract][Full Text] [Related]
32. HLA-DR5 antigen. A genetic factor influencing the outcome of hepatitis C virus infection?
Peano G; Menardi G; Ponzetto A; Fenoglio LM
Arch Intern Med; 1994 Dec 12-26; 154(23):2733-6. PubMed ID: 7993158
[TBL] [Abstract][Full Text] [Related]
33. Human leukocyte antigen alleles and the response to pegylated interferon/ribavirin therapy in chronic hepatitis C patients.
Dai CY; Chuang WL; Hsieh MY; Huang JF; Lin YY; Chu PY; Hou NJ; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
Antiviral Res; 2010 Feb; 85(2):396-402. PubMed ID: 19931565
[TBL] [Abstract][Full Text] [Related]
34. Monotherapy with peginterferon alpha-2b {12 kDa} for chronic hepatitis C infection in patients undergoing haemodialysis.
Amarapurkar DN; Patel ND; Kirpalani AL
Trop Gastroenterol; 2007; 28(1):16-8. PubMed ID: 17896604
[TBL] [Abstract][Full Text] [Related]
35. Human leukocyte antigen class I alleles can predict response to pegylated interferon/ribavirin therapy in chronic hepatitis C Egyptian patients.
Farag RE; Arafa MM; El-Etreby S; Saudy NS; Eldeek BS; El-Alfy HA; Goda IF; Ali RM
Arch Iran Med; 2013 Feb; 16(2):68-73. PubMed ID: 23360626
[TBL] [Abstract][Full Text] [Related]
36. The response to pegylated interferon alpha 2a in haemodialysis patients with hepatitis C virus infection.
Akhan SC; Kalender B; Ruzgar M
Infection; 2008 Aug; 36(4):341-4. PubMed ID: 18629437
[TBL] [Abstract][Full Text] [Related]
37. HLA-E variants are associated with sustained virological response in HIV/hepatitis C virus-coinfected patients on hepatitis C virus therapy.
Guzmán-Fulgencio M; Berenguer J; Rallón N; Fernández-Rodríguez A; Miralles P; Soriano V; Jiménez-Sousa MA; Cosín J; Medrano J; García-Álvarez M; López JC; Benito JM; Resino S
AIDS; 2013 May; 27(8):1231-8. PubMed ID: 23811951
[TBL] [Abstract][Full Text] [Related]
38. HLA-B*15:02 is associated with anemia in patients with chronic hepatitis C treated with pegylated interferon-α and ribavirin.
Tseng CW; Hsieh YH; Chang CK; Lai NS; Hung TH; Wu SF; Tseng KC
Tissue Antigens; 2012 Nov; 80(5):424-30. PubMed ID: 22931407
[TBL] [Abstract][Full Text] [Related]
39. [Treatment of chronic hepatitis C virus infection in hemodialysis patients].
Kaya S
Mikrobiyol Bul; 2008 Jul; 42(3):525-34. PubMed ID: 18822900
[TBL] [Abstract][Full Text] [Related]
40. Interferon alpha monotherapy for chronic hepatitis C viral infection in thalassemics and hemodialysis patients.
Artan R; Akcam M; Yilmaz A; Kocacik D
J Chemother; 2005 Dec; 17(6):651-5. PubMed ID: 16433196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
